110 related articles for article (PubMed ID: 28089218)
1. NKG2D Signaling: The Immune Subversive Side of HDAC3.
Folgueras AR; Gonzalez S; López-Soto A
Trends Immunol; 2017 Mar; 38(3):151-153. PubMed ID: 28089218
[TBL] [Abstract][Full Text] [Related]
2. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.
Lodoen M; Ogasawara K; Hamerman JA; Arase H; Houchins JP; Mocarski ES; Lanier LL
J Exp Med; 2003 May; 197(10):1245-53. PubMed ID: 12756263
[TBL] [Abstract][Full Text] [Related]
3. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.
Slavuljica I; Busche A; Babić M; Mitrović M; Gašparović I; Cekinović D; Markova Car E; Pernjak Pugel E; Ciković A; Lisnić VJ; Britt WJ; Koszinowski U; Messerle M; Krmpotić A; Jonjić S
J Clin Invest; 2010 Dec; 120(12):4532-45. PubMed ID: 21099111
[TBL] [Abstract][Full Text] [Related]
4. Cutting Edge: NKG2D Signaling Enhances NK Cell Responses but Alone Is Insufficient To Drive Expansion during Mouse Cytomegalovirus Infection.
Nabekura T; Gotthardt D; Niizuma K; Trsan T; Jenus T; Jonjic S; Lanier LL
J Immunol; 2017 Sep; 199(5):1567-1571. PubMed ID: 28760883
[TBL] [Abstract][Full Text] [Related]
5. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.
Andoniou CE; van Dommelen SL; Voigt V; Andrews DM; Brizard G; Asselin-Paturel C; Delale T; Stacey KJ; Trinchieri G; Degli-Esposti MA
Nat Immunol; 2005 Oct; 6(10):1011-9. PubMed ID: 16142239
[TBL] [Abstract][Full Text] [Related]
6. HDAC3 represses the expression of NKG2D ligands ULBPs in epithelial tumour cells: potential implications for the immunosurveillance of cancer.
López-Soto A; Folgueras AR; Seto E; Gonzalez S
Oncogene; 2009 Jun; 28(25):2370-82. PubMed ID: 19430493
[TBL] [Abstract][Full Text] [Related]
7. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.
Lodoen MB; Abenes G; Umamoto S; Houchins JP; Liu F; Lanier LL
J Exp Med; 2004 Oct; 200(8):1075-81. PubMed ID: 15477345
[TBL] [Abstract][Full Text] [Related]
8. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice.
Zafirova B; Mandarić S; Antulov R; Krmpotić A; Jonsson H; Yokoyama WM; Jonjić S; Polić B
Immunity; 2009 Aug; 31(2):270-82. PubMed ID: 19631564
[TBL] [Abstract][Full Text] [Related]
9. NKG2D stimulation of CD8
Kavazović I; Lenartić M; Jelenčić V; Jurković S; Lemmermann NAW; Jonjić S; Polić B; Wensveen FM
Eur J Immunol; 2017 Jul; 47(7):1123-1135. PubMed ID: 28378389
[TBL] [Abstract][Full Text] [Related]
10. Differential susceptibility of RAE-1 isoforms to mouse cytomegalovirus.
Arapovic J; Lenac T; Antulov R; Polic B; Ruzsics Z; Carayannopoulos LN; Koszinowski UH; Krmpotic A; Jonjic S
J Virol; 2009 Aug; 83(16):8198-207. PubMed ID: 19494006
[TBL] [Abstract][Full Text] [Related]
11. Ly49C Impairs NK Cell Memory in Mouse Cytomegalovirus Infection.
Forbes CA; Scalzo AA; Degli-Esposti MA; Coudert JD
J Immunol; 2016 Jul; 197(1):128-40. PubMed ID: 27233959
[TBL] [Abstract][Full Text] [Related]
12. A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression.
Greene TT; Tokuyama M; Knudsen GM; Kunz M; Lin J; Greninger AL; DeFilippis VR; DeRisi JL; Raulet DH; Coscoy L
Elife; 2016 Nov; 5():. PubMed ID: 27874833
[TBL] [Abstract][Full Text] [Related]
13. Viral inhibitors of NKG2D ligands: friends or foes of immune surveillance?
Jonjić S; Polić B; Krmpotić A
Eur J Immunol; 2008 Nov; 38(11):2952-6. PubMed ID: 18979514
[TBL] [Abstract][Full Text] [Related]
14. The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3.
Ni L; Wang L; Yao C; Ni Z; Liu F; Gong C; Zhu X; Yan X; Watowich SS; Lee DA; Zhu S
Sci Rep; 2017 Mar; 7():45266. PubMed ID: 28338101
[TBL] [Abstract][Full Text] [Related]
15. Interferon-Dependent Induction of Clr-b during Mouse Cytomegalovirus Infection Protects Bystander Cells from Natural Killer Cells via NKR-P1B-Mediated Inhibition.
Kirkham CL; Aguilar OA; Yu T; Tanaka M; Mesci A; Chu KL; Fine JH; Mossman KL; Bremner R; Allan DSJ; Carlyle JR
J Innate Immun; 2017; 9(4):343-358. PubMed ID: 28288457
[TBL] [Abstract][Full Text] [Related]
16. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
Front Immunol; 2018; 9():991. PubMed ID: 29867968
[TBL] [Abstract][Full Text] [Related]
17. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide.
Madera S; Rapp M; Firth MA; Beilke JN; Lanier LL; Sun JC
J Exp Med; 2016 Feb; 213(2):225-33. PubMed ID: 26755706
[TBL] [Abstract][Full Text] [Related]
18. Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features.
Šustić M; Cokarić Brdovčak M; Lisnić B; Materljan J; Juranić Lisnić V; Rožmanić C; Indenbirken D; Hiršl L; Busch DH; Brizić I; Krmpotić A; Jonjić S
Front Immunol; 2021; 12():681380. PubMed ID: 34168650
[TBL] [Abstract][Full Text] [Related]
19. MyD88 is an essential regulator of NK cell-mediated clearance of MCMV infection.
Dixon KJ; Siebert JR; Wang D; Abel AM; Johnson KE; Riese MJ; Terhune SS; Tarakanova VL; Thakar MS; Malarkannan S
Mol Immunol; 2021 Sep; 137():94-104. PubMed ID: 34242922
[TBL] [Abstract][Full Text] [Related]
20. Ras activation induces expression of Raet1 family NK receptor ligands.
Liu XV; Ho SS; Tan JJ; Kamran N; Gasser S
J Immunol; 2012 Aug; 189(4):1826-34. PubMed ID: 22798674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
